Rob has 20 years of commercial experience in Life Sciences with over a decade of experience in Cell and Gene Therapy supporting customers from pre-clinical to commercialization. With senior roles at Cytiva, Lonza, Miltenyi Biotec and Cambridge Consultants, Rob has significant experience working with customers to optimize and streamline their cell therapy process development and manufacturing workflows.  Additionally, he has supported product development and innovation initiatives with both therapy developers and tool providers to bring new technologies to the cell therapy market.  With a passion to advance and democratize cell therapies to allow better access of these life-saving therapies for patients in need, Rob leads Cytiva’s Cell Therapy commercial team for the Americas.